Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 210
Ultrasensitive mutation detection to enable cancer detection and treatment
Luis A. Diaz
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-3:00 PM
Enabling the early detection of pancreatic cancer
Alison P. Klein
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-3:00 PM
Incorporating molecular pathology tools into epidemiological studies of colorectal cancer
Ulrike Peters
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-3:00 PM
Introduction
Cornelia Liu Trimble
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
High-dimensional immune monitoring of tumor tissues for cancer immunotherapy
Sacha Gnjatic
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Targeting pathogen-induced malignancies: Lessons learned from adoptive T cell transfer for merkel cell carcinoma
Aude G. Chapuis
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Developing a biomarker platform to serve targeted therapy and immunotherapy
Keith T Flaherty
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
High-dimensional analyses of the mucosal microenvironment in precancerous, intraepithelial cervical HPV disease
Cornelia L. Trimble
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Invited Speaker
Jeffrey S. Miller
Univ. of Minnesota, Minneapolis, MN, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Ronny I. Drapkin
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Rare and common risk alleles: Cancer prevention and care for individuals and populations
Peter Kraft
Harvard T.H. Chan School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
The evolving landscape of cancer susceptibility associated with high-penetrance gene mutations
Katherine L. Nathanson
Univ. of Pennsylvania School of Medicine, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Three components of inherited cancer risk and their implications in personalized cancer screening
Jianfeng Xu
Northshore University Health Systems, Evanston, IL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial
Roger Stupp
University Hospital Zurich & Northwestern University, Zurich & Chicago, Switzerland
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Phase I study of the alpha specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent ovarian and breast cancer: Analysis of the dose escalation and ovarian cancer expansion cohort
Panagiotis A Konstantinopoulos
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Targeting MUC16 with the THIOMABTM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: a Phase I escalation study
Joyce F Liu
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor
Ruth O'Regan
University of Wisconsin Carbone Cancer Center, Madison, WI, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Circulating tumor DNA (ctDNA) sequencing for HER2 mutation (HER2mut) screening and response monitoring to neratinib in metastatic breast cancer (MBC)
Cynthia Ma
Washington University School of Medicine, St. Louis, MO, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Novel effect of tamoxifen therapy: disruption of ER-p53 interaction leading to altered gene expression profile in human breast tumors
Gokul M. Das
Roswell Park Cancer Inst., Buffalo, NY, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DMI) with neratinib (N) in women with metastatic HER2+ breast cancer (MBC)
Jame Abraham
NSABP, and The Cleveland Clinic, Cleveland, OH, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Invited Speaker
Jody S. Rosenblatt
Huntsman Cancer Institute, Salt Lake City, UT, United States
from AACR Annual Meeting 2017 on April 3, 2017 7:00 AM-8:00 AM
Towards a national strategy to increase HPV vaccination
Electra D. Paskett
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Using implementation science to reduce urban and rural cancer disparities
Celette S. Skinner
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Improving implementation of tobacco treatment guidelines in public dental care
Jamie S Ostroff
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Closing Remarks
Maria Elena Martinez
UCSD Moores Cancer Ctr., La Jolla, CA, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 210